Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer (Q34781970)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer |
scientific article |
Statements
1 reference
Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer (English)
1 reference
David S Alberts
1 reference
Setsuko K Chambers
1 reference
Mary C Clouser
1 reference
Amanda F Baker
1 reference
Denise J Roe
1 reference
Haiyan Cui
1 reference
Molly A Brewer
1 reference
Kenneth D Hatch
1 reference
Michael S Gordon
1 reference
Mike F Janicek
1 reference
Jeffrey D Isaacs
1 reference
Alan N Gordon
1 reference
Raymond B Nagle
1 reference
Heather M Wright
1 reference
Janice L Cohen
1 reference
1 November 2010
1 reference
1 reference
16
1 reference
21
1 reference
5320-5328
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference